Why docosapentaenoic acid is not included in the Omega-3 Index

2018 ◽  
Vol 135 ◽  
pp. 18-21 ◽  
Author(s):  
Clemens von Schacky ◽  
William S. Harris
Marine Drugs ◽  
2020 ◽  
Vol 18 (2) ◽  
pp. 118 ◽  
Author(s):  
Xingyu Zhu ◽  
Shuangfei Li ◽  
Liangxu Liu ◽  
Siting Li ◽  
Yanqing Luo ◽  
...  

Thraustochytriidae sp. have broadly gained attention as a prospective resource for the production of omega-3 fatty acids production in significant quantities. In this study, the whole genome of Thraustochytriidae sp. SZU445, which produces high levels of docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA), was sequenced and subjected to protein annotation. The obtained clean reads (63.55 Mb in total) were assembled into 54 contigs and 25 scaffolds, with maximum and minimum lengths of 400 and 0.0054 Mb, respectively. A total of 3513 genes (24.84%) were identified, which could be classified into six pathways and 44 pathway groups, of which 68 genes (1.93%) were involved in lipid metabolism. In the Gene Ontology database, 22,436 genes were annotated as cellular component (8579 genes, 38.24%), molecular function (5236 genes, 23.34%), and biological process (8621 genes, 38.42%). Four enzymes corresponding to the classic fatty acid synthase (FAS) pathway and three enzymes corresponding to the classic polyketide synthase (PKS) pathway were identified in Thraustochytriidae sp. SZU445. Although PKS pathway-associated dehydratase and isomerase enzymes were not detected in Thraustochytriidae sp. SZU445, a putative DHA- and DPA-specific fatty acid pathway was identified.


Nutrients ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2751
Author(s):  
Stefania D’Angelo ◽  
Maria Letizia Motti ◽  
Rosaria Meccariello

Recently, nutraceutical bioactive compounds in foods have been discovered for their potential health benefits regarding the prevention of chronic disorders, such as cancer, and inflammatory, cardiovascular, and metabolic diseases. Dietary omega-3 polyunsaturated fatty acids (ω-3PUFAs), including alpha-linolenic acid, docosapentaenoic acid, and eicosapentaenoic acid, are mostly attractive. They are available for the customers worldwide from commonly used foods and/or as components of commercial food supplements. The anti-inflammatory and hypotriglyceridemic effects of these fatty acids are well known, whereas pro-inflammatory properties have been recognized in their dietary counterparts, the ω-6PUFAs. Both ω-3 and ω-6PUFAs contribute to the production of lipid mediators such as endocannabinoids that are notably involved in control of food intake, energy sensing, and food–related disorders. In this review, we present ω-3 and ω-6PUFAs and their derivatives, endocannabinoids; discuss the anti-obesity effects of ω-3PUFAs; their roles in inflammation and colorectal cancer development; and how their action can be co-preventative and co-therapeutic.


Reproduction ◽  
2013 ◽  
Vol 146 (6) ◽  
pp. 603-614 ◽  
Author(s):  
U Moallem ◽  
A Shafran ◽  
M Zachut ◽  
I Dekel ◽  
Y Portnick ◽  
...  

The objectives of this study were to determine the differential incorporation of various omega-3 (n-3) fatty acids (FAs) supplemented to dairy cows into ovarian compartments and assess the effects on IVF. Forty-two 256-day pregnant cows were supplemented with encapsulated fats, in treatments designated as i) SFA – saturated fat at 240 and 560 g/day per cow, prepartum and post partum (PP) respectively; ii) FLX – flaxseed oil at 300 and 700 g/day per cow prepartum and PP respectively; and iii) FO – fish oil at 300 and 700 g/day per cow prepartum and PP respectively. Commencing at 60 days in lactation, ovum pickup (OPU) was performed twice weekly (20 sessions; five cows per group) and in vitro maturation and IVF were conducted. The proportion of α-linolenic acid (ALA) was greater in follicular fluid (FF), granulosa cells, and cumulus–oocyte complexes (COCs) of FLX cows than in other groups (P<0.001). The proportion of docosahexaenoic acid (DHA) was 6.7 times as great in FF of FO as in other groups (P<0.001); docosapentaenoic acid n-3 and DHA were detected in COCs of FO but not in others. The follicle number during OPU was higher in FLX and FO than in SFA (P<0.05), and the oocyte cleavage rate was higher in FLX and FO than in SFA (P<0.01). Also, the percentage of oocytes that developed to blastocysts tended to be higher in both n-3 groups than in SFA (P<0.1). In conclusion, both dietary n-3 FAs similarly improved folliculogenesis and IVF performance; therefore, ALA-rich botanical n-3 seems to be a satisfactory approach to improve oocyte quality.


Author(s):  
IDA MUSFIROH ◽  
GINNA MEGAWATI ◽  
DEWI MARHENI DIAH HERAWATI ◽  
AGUS RUSDIN

Objective: The aim of this work was to study the pharmacophore model of omega-3 derivatives with the PPAR-γ receptor using LigandScout 4.4.3 to investigate the important chemical interactions of complex structure. Methods: The methods consisted of structure preparation of nine chemical compounds derived from omega-3 fatty acids, database preparation, creating 3D Pharmacophore modelling, validation pharmacophore, and screening test compounds. Results: The result of the research showed that the omega-3 derivatives docosahexaenoic acid (DHA), when eicosapentaenoic acid (HPA), and docosapentaenoic acid (DPA) have the best pharmacophore fit values of 36.59; 36.56; and 36.56, respectively. According to the results of the pharmacophore study, the carbonyl and hydroxyl of the carboxylate functional groups become the active functional groups that exhibit hydrogen bonding interactions. While the alkyl chain (Ethyl and methyl groups) was the portion that can be modified to increase its activity. Conclusion: Omega-3 derivatives could be used as a lead drug for the powerful PPAR-γ receptor in the prevention and treatment of obesity.


Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Nisar A Shaikh ◽  
Sabah N Shaikh ◽  
Jason Yantha ◽  
George Jackowski

Background: A relationship of regular fish consumption with lowered incidence of cardiovascular disease (CVD) has been appreciated for decades. However, preparations from fish oils, showed mixed results in recent meta-analyses and have raised some doubts on the efficacy of omega-3 polyunsaturated fatty acids (ω-3 PUFA) for management of CVD. Some of these reports suffer from inclusion of studies with ill-defined patient populations, varying PUFA doses, purity, and formulation, while others have patients on drug milieu or have employed placebo that could have undermine the trial outcome. Very few studies have determined ω-3 PUFA levels pre & post treatment. In this report, we are the first to describe heterogeneity of Omega 3 uptake among trial subjects that could have contributed to the inconsistencies of results. Methods: In VASCAZEN-REVEAL trials, 54 subjects with normal to high blood triglycerides levels (TG 90-500mg/dl) and with ω-3 PUFA deficiency (Omega-Score™, OS, blood levels of eicosapentaenoic (EPA)+docosahexaenoic (DHA) +docosapentaenoic acid (DPA) of <6.1% of total blood fatty acids) were provided 4g/day of 6:1 EPA/DHA formulation (>90% purity) for 8 weeks. Changes in the OS levels pre-and post treatment along with individual fatty acids including arachidonic (AA) were determined and desaturation enzymes activities were calculated. Results: Based upon post-treatment increases in the blood levels of OS, weak (WR), intermediate (IR) and strong (SR) responders were identified. Conclusion: This is the first report to show differential effect of Omega-3 on trial subjects and warrants caution in the interpretation of trial data without identifying the responders.


BMJ ◽  
2018 ◽  
pp. k4067 ◽  
Author(s):  
Heidi TM Lai ◽  
Marcia C de Oliveira Otto ◽  
Rozenn N Lemaitre ◽  
Barbara McKnight ◽  
Xiaoling Song ◽  
...  

AbstractObjectiveTo determine the longitudinal association between serial biomarker measures of circulating omega 3 polyunsaturated fatty acid (n3-PUFA) levels and healthy ageing.DesignProspective cohort study.SettingFour communities in the United States (Cardiovascular Health Study) from 1992 to 2015.Participants2622 adults with a mean (SD) age of 74.4 (4.8) and with successful healthy ageing at baseline in 1992-93.ExposureCumulative levels of plasma phospholipid n3-PUFAs were measured using gas chromatography in 1992-93, 1998-99, and 2005-06, expressed as percentage of total fatty acids, including α-linolenic acid from plants and eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid from seafoood.Main outcome measureHealthy ageing defined as survival without chronic diseases (ie, cardiovascular disease, cancer, lung disease, and severe chronic kidney disease), the absence of cognitive and physical dysfunction, or death from other causes not part of the healthy ageing outcome after age 65. Events were centrally adjudicated or determined from medical records and diagnostic tests.ResultsHigher levels of long chain n3-PUFAs were associated with an 18% lower risk (95% confidence interval 7% to 28%) of unhealthy ageing per interquintile range after multivariable adjustments with time-varying exposure and covariates. Individually, higher eicosapentaenoic acid and docosapentaenoic acid (but not docosahexaenoic acid) levels were associated with a lower risk: 15% (6% to 23%) and 16% (6% to 25%), respectively. α-linolenic acid from plants was not noticeably associated with unhealthy ageing (hazard ratio 0.92, 95% confidence interval 0.83 to 1.02).ConclusionsIn older adults, a higher cumulative level of serially measured circulating n3-PUFAs from seafood (eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid), eicosapentaenoic acid, and docosapentaenoic acid (but not docosahexaenoic acid from seafood or α-linolenic acid from plants) was associated with a higher likelihood of healthy ageing. These findings support guidelines for increased dietary consumption of n3-PUFAs in older adults.


Molecules ◽  
2020 ◽  
Vol 25 (20) ◽  
pp. 4615
Author(s):  
Ivonne Lozano-Muñoz ◽  
Susana Muñoz ◽  
Nelson F. Díaz ◽  
Alberto Medina ◽  
Jazmín Bazaes ◽  
...  

Omega-3 long-chain polyunsaturated fatty acids (n-3 LC PUFAs) and vitamin D3 are essential components of human nutrition. A regular human diet is highly deficient in n-3 LC PUFAs. Fish like salmon are highly recommended in the human diet as they are a major source of high-value n-3 LC PUFAs and vitamin D3. The levels of these nutrients have been decreasing over the last few years in farmed salmon, whose production urgently needs sustainable sources of these nutrients. The microalga Nannochloropsis gaditana (NG) is known for its naturally high potential for the production of eicosapentaenoic (EPA, 20:5 n-3) fatty acid. A commercial diet for Atlantic salmon was supplemented with 1% and 10% of spray-dried NG grown under controlled conditions for a high EPA content. Salmon were harvested on day 49, following which, boneless and skinless salmon meat was recovered from fish and analyzed for the fatty acid profile, total fat, and vitamin D3. Vitamin D3, EPA, and docosapentaenoic fatty acid (DPA, 22:5 n-3) levels were significantly increased (p < 0.05) by supplementing the basal diet with 10% NG, thus, NG represents a novel, functional, natural ingredient and a sustainable source of n-3 LC-PUFAs that can raise the levels of healthy fats and vitamin D3 in farmed salmon meat.


2018 ◽  
Vol 58 (4) ◽  
pp. 1429-1439 ◽  
Author(s):  
I. S. M. van der Wurff ◽  
C. von Schacky ◽  
T. Bergeland ◽  
R. Leontjevas ◽  
M. P. Zeegers ◽  
...  

AbstractPurposeDepression is common in adolescents and long-chain polyunsaturated fatty acids (LCPUFA) are suggested to be associated with depression. However, research in adolescents is limited. Furthermore, self-esteem has never been studied in relation to LCPUFA. The objective here was to determine associations of depression and self-esteem with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), Omega-3 Index (O3I), n-6 docosapentaenoic acid (n-6 DPA, also called Osbond acid, ObA), n-3 docosapentaenoic acid (DPA), and arachidonic acid (AA) concentrations in blood of adolescents attending lower general secondary education (LGSE).MethodsBaseline cross-sectional data from a krill oil supplementation trial in adolescents attending LGSE with an O3I ≤ 5% were analysed using regression models built with the BayesFactor package in R. Fatty acids and O3I were determined in blood. Participants filled out the Centre for Epidemiologic Studies Depression (CES-D) scale and the Rosenberg Self-Esteem scale (RSE).ResultsScores indicative of depression (CES-D ≥ 16) were found in 29.4% of the respondents. Of all fatty acids, we found extreme evidence [Bayes factor (BF) > 100] for a weak negative association between ObA and depression score [− 0.16; 95% credible interval (CI) − 0.28 to − 0.04; BF10 = 245], and substantial evidence for a weak positive association between ObA and self-esteem score (0.09; 95% CI, − 0.03 to 0.20; BF10 = 4). When all fatty acids were put in one model as predictors of CES-D or RSE, all of the 95% CI contained 0, i.e., no significant association.ConclusionNo evidence was found for associations of DHA, EPA and O3I with depression or self-esteem scores in LGSE adolescents with O3I ≤ 5%. The associations of higher ObA status with lower depression and higher self-esteem scores warrant more research.


2010 ◽  
Vol 50 (2) ◽  
pp. 130 ◽  
Author(s):  
Soressa Kitessa ◽  
Shimin Liu ◽  
Jan Briegel ◽  
David Pethick ◽  
Graham Gardner ◽  
...  

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the n-3 polyunsaturated fatty acids (n-3 PUFA) for which there is ample evidence of human health benefits, and these are also the fatty acids for which there are cut-off points for ‘source’ and ‘good source’ claims. Two consecutive experiments were conducted to determine the effect of finishing systems on the n-3 PUFA content of lamb meat in Western Australia. In experiment I, a 4-week feeding experiment was conducted using 48 Poll Dorset × Merino lambs. The lambs were divided into two lots of 24 (12 males and 12 females) and randomly assigned to either concentrate (C1) finishing on commercial lamb finishing pellets or pasture (P) finishing on kikuyu (Pennisetum clandestinum) pasture. In experiment II, 28 lambs were divided into two groups of 14 lambs (seven males and seven females) and assigned to finishing either on concentrate pellets (C2) or concentrate pellets plus linseed (C2-L). This second experiment was conducted indoors for 10 weeks. The initial liveweight (mean ± s.e.) of the lambs was 43 ± 0.6 and 32.5 ± 0.9 kg for experiments I and II, respectively. At the end of experiment II, three chops each were sampled from the leg, loin, forequarter and neck region of each carcass. The final liveweight (42 ± 0.8 v. 50 ± 1.2 kg), hot carcass weight (19 ± 0.5 v. 24 ± 0.7 kg) and GR depth (5.6 ± 0.6 v. 12.8 ± 0.6 mm) were lower (P < 0.05) for P than C1 lambs. In contrast, C2 and C2-L lambs had similar final liveweight (44 ± 0.7 v. 45 ± 0.9 kg), hot carcass weight (19 ± 0.3 v. 20 ± 0.5 kg) and GR depth (13 ± 1.3 v. 14 ± 1.2 mm). In experiment I, the total n-3 PUFA yields for C1 and P lambs in the M. longissimus lumborum were 67 ± 2.5 and 78 ± 3.2 mg per 100 g muscle, respectively. The EPA plus DHA yields were 17 and 21 mg per 100 g muscle, respectively. The sum of the long-chain (≥C20) n-3 PUFA EPA, docosapentaenoic acid and DHA for C1 and P lambs were 30 and 37 mg per 100 g, respectively. Sex had no effect on any of the n-3 fatty acids. In experiment II, the total n-3 PUFA yields for C2 lambs were 61, 54, 60 and 104 mg per 100 g for leg, loin, forequarter and neck chops, respectively. The respective values for C2-L lambs were 153, 138, 139 and 178 mg per 100 g muscle. The claimable EPA plus DHA yields for C2 lambs were 13, 10, 12 and 15 mg per 100 g of trimmed leg, loin, forequarter and neck chops, respectively. The respective values for C2-L lambs were around 2-fold higher at 27, 21, 25 and 23 mg per 100 g raw meat. All the samples from pasture-finished and linseed-supplemented groups met the 30 mg cut-off point for ‘source’ claim in Australia when the computation was based on 100 g cooked lamb serve (140 g raw). We conclude that pasture-finished lambs have more n-3 PUFA per serve than their counterparts finished indoors on commercial pellets. Further, supplementing indoor-finished lambs with linseed provided equivalent n-3 PUFA per serve to finishing lambs on pasture. Supplementation with an omega-3 source improved omega-3 per serve across the whole carcass irrespective of sex.


2018 ◽  
Vol 4 ◽  
Author(s):  
Zhongshui Yu ◽  
Jiankang Wang ◽  
Fereidoon Shahidi

The objective of this study was to concentrate polyunsaturated fatty acid (PUFA) from seal blubber oil in an innovative manner to produce a high content of docosapentaenoic acid (DPA) in the resultant product. It also aimed at investigating the use of lipases as catalysts for synthesizing acylglycerols from glycerol and polyunsaturated fatty acid concentrates. Additionally, study of the oxidative stability of acylglycerols synthesized by lipases was intended. A two-stage urea complexation process was used to concentrate PUFA from seal blubber oil, giving rise to a DPA content of up to 24.0% in the product. Enzymatic synthesis of acyglycerols directly from glycerol and fatty acid concentrate was studied. Three lipases were used as biocatalysts for esterification. Lipase SP435 from Candida antarctica showed the highest activity for esterification. Effects of reaction parameters, namely temperature, time course and mole ratio of glycerol to fatty acid were followed with all three lipases. The optimal reaction time was 24 hr at 30 °C at a mole ratio of glycerol to fatty acid of 14:1. The maximum degree of acylglycerol synthesis was > 90%. The effect of time course and mole ratio of glycerol to fatty acid on acylglycerols distribution was also determined. The oxidative stability of different samples under Schaal-oven conditions at 60 °C showed that the oxidative stability of acylglycerols was better than that of the corresponding fatty acid esters.


Sign in / Sign up

Export Citation Format

Share Document